|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/439 | (2006.01) |
| A61K 31/439 | (2013.01) | ||
| A61P 25/34 | (2006.01) | ||
| A61P 25/34 | (2018.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61K 9/4858 | (2013.01) | ||
| A61K 9/4866 | (2013.01) |
| (11) | Patento numeris | 3411029 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17704814.7 |
| Europos patento paraiškos padavimo data | 2017-02-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2017/050294 |
| Data | 2017-02-06 |
| (87) | Numeris | WO 2017/134468 |
| Data | 2017-08-10 |
| (30) | Numeris | Data | Šalis |
| 201602145 | 2016-02-05 | GB |
| (72) |
CLARKE, Anthony , GB
STEWART, Richard Allistair , GB
WILLIS, Andrew Gareth , GB
|
| (73) |
Achieve Pharma UK Limited ,
10 Station Road, Henley-on-Thames, Oxfordshire RG9 1AY,
GB
|
| (54) | SUCCINATE SALT OF CYTISINE AND USE THEREOF |
| SUCCINATE SALT OF CYTISINE AND USE THEREOF |